Showing results (81-90 of 1,752) with videos related to

Sort By:
Pageof 176
The Journal of Clinical Investigation|March 1, 1992
Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrilsM Ryynänen, J Ryynänen, S Sollberg, et al.
Blood|August 1, 1996
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID miceT Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Genomics|December 1, 1992
Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14)R V Iozzo, M F Naso, L A Cannizzaro, et al.
The Journal of Clinical Investigation|July 1, 1997
Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinasesM Santra, D M Mann, E W Mercer, et al.
The Journal of Biological Chemistry|June 15, 2001
A composite element binding the vitamin D receptor and the retinoic X receptor alpha mediates the transforming growth factor-beta inhibition of decorin gene expression in articular chondrocytesM Demoor-Fossard, P Galéra, M Santra, et al.
The Journal of Surgical Research|October 1, 1985
Early diagnosis of experimental necrotizing enterocolitis using proton nuclear magnetic resonanceJ E Miller, G J Whitman, R V Iozzo, et al.
The Journal of Clinical Investigation|April 1, 1994
Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-betaL Rudnicka, J Varga, A M Christiano, et al.
Genomics|September 1, 1995
Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13M F Naso, J L Morgan, A M Buchberg, et al.
Calcified Tissue International|November 12, 2005
Targeted disruption of two small leucine-rich proteoglycans, biglycan and decorin, excerpts divergent effects on enamel and dentin formationM Goldberg, D Septier, O Rapoport, et al.
The Journal of Clinical Investigation|October 28, 1998
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivoB Sharma, M Handler, I Eichstetter, et al.
Pageof 176